AKAM
56
-2
EIX
69
-5
MRK
53
3
DRI
64
4
ADI
56
-3
SE
65
4
WU
16
2
PNR
72
-2
PYPL
45
-2
PEP
50
-4
NWL
32
-3
PLD
51
-5
NTRS
47
-2
SYY
50
-8
GT
46
3
TRV
64
-3
DTE
56
-7
HPQ
62
2
ABBV
51
-2
THC
61
3
AKAM
56
-2
EIX
69
-5
MRK
53
3
DRI
64
4
ADI
56
-3
SE
65
4
WU
16
2
PNR
72
-2
PYPL
45
-2
PEP
50
-4
NWL
32
-3
PLD
51
-5
NTRS
47
-2
SYY
50
-8
GT
46
3
TRV
64
-3
DTE
56
-7
HPQ
62
2
ABBV
51
-2
THC
61
3
Financhill
Back

Vir Biotechnology Quote, Financials, Valuation and Earnings

Hedge fund manager warns about the market ahead

Free book prepares you for the coming uncertainty in the stock market
Sell
19

VIR
Vir Biotechnology

Last Price:
7.92
Seasonality Move:
6.96%

7 Day Trial

ALL ACCESS PASS

$ 7

How this hedge fund manager trades weekly options

Claim your free training on trading weekly options

Vir Biotechnology Price Quote

$7.92
-0.02 (1.41%)
(Updated: September 20, 2024 at 4:27 AM ET)

Vir Biotechnology Key Stats

Sell
19
Vir Biotechnology (VIR) is a Sell
Day range:
$7.83 - $8.14
52-week range:
$7.41 - $13.09
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
18.61
P/B ratio:
0.76%
Volume:
503.5K
Avg. volume:
676K
1-year change:
-19.39%
Market cap:
$1.1B
Revenue:
$39.5M
EPS:
$-3.58

How Much Does Vir Biotechnology Make?

Is Vir Biotechnology Growing As A Company?

Data Unavailable

Vir Biotechnology Stock Price Performance

  • Did Vir Biotechnology Stock Go Up Last Month?
    Vir Biotechnology share price went down by -9.46% last month
  • Did VIR's Share Price Rise Over The Last Year?
    VIR share price fell by -19.39% over the past 1 year

What Is Vir Biotechnology 52-Week High & Low?

Vir Biotechnology Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vir Biotechnology?

  • How Much Debt Does Vir Biotechnology Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Vir Biotechnology Have?
    Cash and short term investments quarterly total is $1.2B
  • What Is Vir Biotechnology’s Book Value Per Share?
    Book value per share is 10.50

Is Vir Biotechnology Cash Flow Positive?

  • What Is VIR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$451M
  • What Is Vir Biotechnology’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $5.1M
  • What Is Vir Biotechnology’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $76.3M

Vir Biotechnology Return On Invested Capital

  • Is Management Doing A Good Job?
    VIR return on invested capital is -29.98%
  • What Is Vir Biotechnology Return On Assets?
    ROA measures how assets are converting to revenues and is -24.97%
  • What Is VIR Return On Equity?
    ROE is a measure of profitability and is -29.98%

Vir Biotechnology Earnings Date & Stock Price

Vir Biotechnology Competitors

  • Who Are Vir Biotechnology's Competitors?
    Below is a list of companies who compete with Vir Biotechnology or are related in some way:
    • Axsome Therapeutics Inc (AXSM)
    • Moderna Inc (MRNA)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Pfizer Inc (PFE)
    • Palatin Technologies Inc (PTN)

Vir Biotechnology Dividend Yield

Vir Biotechnology Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -14.05%
Revenue: 0% -58.98%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 31.25
Upside from Last Price: 293.58%

Major Shareholders

  • How many VIR shares are owned by institutional investors?
    134.3M VIR shares are owned by institutional investors
  • How many VIR shares are owned by insiders?
    4.8M VIR shares are owned by insiders